Neurogene - 54 Year Dividend History | NGNE

Historical dividend payout and yield for Neurogene (NGNE) since 1971. The current TTM dividend payout for Neurogene (NGNE) as of January 31, 2025 is $0.00. The current dividend yield for Neurogene as of January 31, 2025 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.230B $0.000B
Neurogene Inc. is a clinical-stage company which bring life-changing genetic medicines to patients and families affected by rare neurological diseases. Neurogene Inc., formerly known as Neoleukin Therapeutics Inc., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio